Hu, Jun
Tian, Caijuan
Zhao, Yanpeng
Guo, Yixian
Chen, Shuo
Funding for this research was provided by:
the Chinese Anti-Cancer Association - HengRui Anti-angiogenesis Targeted Tumor Research Fund (2021001045)
The Scientific Research Translational Foundation of Wenzhou Safety (Emergency) Institute of Tianjin University (TJUWYY2022025)
Article History
Received: 21 March 2022
Accepted: 16 June 2022
First Online: 14 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.